[1]于亚静 杨彩哲 关小宏 王良宸 吴石白 刘明 肖黎 张妲 刘朝阳.甲状腺癌与桥本甲状腺炎及其他相关危险因素的研究[J].国际内分泌代谢杂志,2015,(01):27-30.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
　Yu Yajing*,Yang Caizhe,Guan Xiaohong,et al.Relationship between thyroid carcinoma, Hashimoto′s thyroiditis and other related risk factors[J].International Journal of Endocrinology and Metabolism,2015,(01):27-30.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
点击复制

甲状腺癌与桥本甲状腺炎及其他相关危险因素的研究()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2015年01
页码:
27-30
栏目:
短篇论著
出版日期:
2015-01-20

文章信息/Info

Title:
Relationship between thyroid carcinoma, Hashimoto′s thyroiditis and other related risk factors
作者:
于亚静 杨彩哲 关小宏 王良宸 吴石白 刘明 肖黎 张妲 刘朝阳
075000张家口，河北北方学院(于亚静，刘朝阳)；北京空军总医院内分泌科(杨彩哲，关小宏，王良宸，吴石白，肖黎，张妲)，病理科（刘明）
Author(s):
Yu Yajing*; Yang Caizhe; Guan Xiaohong; Wang Liangchen; Wu Shibai; Liu ming; Xiao li; Zhang Da; Liu Chaoyang
.*Hebei North University, Zhangjiakou 075000, China?
关键词:
甲状腺癌; 桥本甲状腺炎; 甲状腺良性结节
Keywords:
Thyroid carcinoma; Hashimotos thyroiditis; Thyroid benign nodules
DOI:
10.3760/cma.j.issn.1673-4157.2015.01.006
摘要:
目的 探讨甲状腺癌与桥本甲状腺炎及其他相关危险因素的关系。 方法 采用回顾性研究方法分析2001年1月—2013年9月于空军总医院经手术治疗的1 141例甲状腺结节患者的临床资料，其中，病理诊断为甲状腺癌270例，甲状腺良性结节871例（甲状腺腺瘤194例，结节性甲状腺肿341例，腺瘤性结节性甲状腺肿336例）。比较甲状腺癌患者及甲状腺良性结节患者在桥本甲状腺炎、性别、年龄、病程、结节大小、甲状腺功能等方面的差异，并采用Logistic回归法分析甲状腺癌的危险因素。 结果 与甲状腺良性结节患者相比，甲状腺癌患者合并桥本甲状腺炎比例较高（t=20.534，P<0.01）、患者较年轻（t=0.855, P<0.01）、结节直径较小(t=-5.927，P<0.01)，促甲状腺激素（TSH）水平(t=2.380,P<0.05)、甲状腺球蛋白抗体异常率 (χ2=16.088,P<0.01)及甲状腺过氧化物酶抗体异常率 (χ2=7.023,P<0.01)均较高。Logistic回归分析显示桥本甲状腺炎[优势比（OR）=1.829，95%CI：1.163~2.877，P<0.01]、年龄≤45岁(OR=1.716，95%CI:1.166~2.528，P<0.01）、结节直径≤1 cm(OR=4.261，95%CI：2.467~7.360，P<0.01)是甲状腺癌的危险因素。 结论 桥本甲状腺炎可能是甲状腺癌的危险因素，对于促甲状腺激素、甲状腺球蛋白抗体、甲状腺过氧化物酶抗体水平较高的甲状腺结节患者应高度关注，加强随访。
Abstract:
Objective To explore the relationship between thyroid carcinoma, Hashimoto′s thyroiditis and other related risk factors. Methods A retrospective analysis was used to analyze 1 141postoperative patients with thyroid nodules in Air Force General hospital during 2001.1—2013.9 .According to the pathological results, there were 270 cases of thyroid carcinomas, 871 cases of thyroid benign nodules including 194 cases of thyroid adenoma, 341 cases of nodular goiter, 336 cases of adenomatous nodular goiter. Difference between patients with thyroid carcinoma and benign thyroid nodules was compared, including the prevalence of Hashimoto′s thyroiditis and other factors such as gender, age, course of disease, size of nodules, thyroid function, etc.Logistic regression analysis was used to explore the risk factors of thyroid carcinoma. Results Compared with patients with benign thyroid nodules, the prevalence of Hashimoto′s thyroiditis was higher(t=20.534,P<0.01), the age was younger(t=0.855,P<0.01), the diameter of the nodules was smaller(t=-5.927,P<0.01) in patients wih thyroid carcinoma.And the level of thyroid stimulating hormone(TSH, t=2.380, P<0.05), the percentage of abnormal thyroid globulin antibody (χ2=16.088,P<0.01)，the percentage of abnormal thyroid peroxidase antibody(χ2=7.023,P<0.01)were all higher in patients with thyroid carcinoma.Logistic regression analysis indicated that Hashimoto′s thyroiditis [odd ratio(OR)=1.829,95%CI:1.163-2.877,P<0.01] age≤45years) (OR=1.716, 95% CI: 1.166- 2.528, P<0.01, the diameter of the nodules≤1 cm(OR=4.261，95% CI：2.467-7.360,P<0.01) were risk factors of thyroid carcinoma. Conclusion Hashimoto′s thyroiditis may be a risk factor of thyroid carcinoma. Besides, more concern and intensive follow up should be recommended for patients with increased TSH, thyroid globulin body,thyroid peroxidase antibody levels.

参考文献/References:


[1]张德言,卢秀波.23例桥本甲状腺炎合并甲状腺癌临床诊疗分析[J].中华内分泌外科杂志,2011,5(5):358-359.
[2]Repplinger D, Bargren A, Zhang YW, et al.Is Hashimoto′s thyroiditis a risk factor for papillary thyroi d cancer? [J].J Surg Res, 2008,150(1):49-52.
[3] Paulson LM, Shindo ML, Schuff KG. Role of chronic lymphocytic thyroiditis in central node metastasis of papillary thyroid carcinoma[J].Otolaryngol Head Neck Surg,2012,147(3):444-449.
[4] Anil C,Goksel S,Gursoy A.Hashimoto′s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a singlecenter prospective study[J].Thyroid,2010,20(6):601-606.
[5] Giagourta I,Evangelopoulou C,Papaioannou G,et al.Autoimmune thyroiditis in benign and malignant thyroid nodules: 16year results[J].Head and Neck,2014,36(4):531-535.
[6] Hatch M,Furukawa K,Brenner A,et al.Prevalence of hyperthyroidism after exposure during childhood or adolescence to radioiodines from the chornobyl nuclear accident: doseresponse results from the UkrainianAmerican Cohort Study[J].Radiat Res,2010,174(6):763-772.
[7] Dong W,Zhang H,Zhang P,et al.The changing incidence of thyroid carcinoma in Shenyang, China before and after universal salt iodization[J].Med Sci Monit,2013, 19: 49-53.
[8] Cunha LL,FerreiraRC,Marcello MA,et al.Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer[J].J Thyroid Res,2011,2011:387062.
[9]李拓，盛建国，李维卿，等．术前良恶性甲状腺结节鉴别诊断评分系统的建立及验证[J]．中华内科杂志,2013,52(11)：945-950．
[10]闫慧娴,谷伟军,吕朝晖,等.不同性别分化型甲状腺癌临床特征比较分析[J].中华内科杂志,2014,53(4):286-289.
[11] Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J]．J Clin Endocrinol Metab,2008,93(3):809-814．
[12]闫慧娴,谷伟军,杨国庆,等.血清促甲状腺激素与甲状腺微小乳头状癌相关性研究[J].中华内分泌代谢杂志,2014,30(8):669672.
[13]刘长路,吴岩,毕立夫．甲状腺癌流行现状及危险因素的研究进展[J]．中国地方病学杂志，2012,31(2):234-236．
[14]Guarino V,Castellone MD, Avilla E, et al. Thyroid cancer and inflammation[J].Mol Cell Endocrinol,2010,321(1):94-102.
[15]Fiore E, Rago T, Latrofa F, et al. Hashimoto′s thyroiditis is associated with papillary thyroid carcinoma:role of TSH and of treatment with Lthyroxine[J].Endocr Relat Cancer,2011,18 (4): 429-437.

相似文献/References:

[1]李兴佳 曹萌 刘超.自噬与甲状腺癌的关系[J].国际内分泌代谢杂志,2015,(01):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
　Li Xingjia,Cao Meng,Liu Chao..Relationship between autophagy and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2015,(01):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
[2]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
　Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(01):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[3]孟祥慧,徐书杭,蔡可英,等.肥胖与甲状腺癌：临床新启示[J].国际内分泌代谢杂志,2014,(02):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
　Meng Xianghui*,Xu Shuhang,Cai Keying,et al.Obesity and thyroid cancer: a new clinical implication[J].International Journal of Endocrinology and Metabolism,2014,(01):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
[4]孙洪平,陈国芳,曹雯,等.糖尿病与甲状腺癌关系的研究进展[J].国际内分泌代谢杂志,2014,(02):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
　Sun Hongping,Chen Guofang,Cao Wen,et al.Diabetes and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2014,(01):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
[5]李秀娟,刘红梅.IgG4相关桥本甲状腺炎的研究进展[J].国际内分泌代谢杂志,2014,(04):257.[doi:10.3760/cma.j.issn.1673-4157.2014.04.012]
　Li Xiujuan,Liu Hongmei..Recent progress of IgG4-related Hashimoto's thyroiditis[J].International Journal of Endocrinology and Metabolism,2014,(01):257.[doi:10.3760/cma.j.issn.1673-4157.2014.04.012]
[6]张倍宁 闫如意 周金莲 崔彦.甲状腺癌中miRNA的表达及作用[J].国际内分泌代谢杂志,2018,38(03):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
　Zhang Beining*,Yan Ruyi,Zhou Jinlian,et al.Expression and function of miRNA in thyroid carcinoma[J].International Journal of Endocrinology and Metabolism,2018,38(01):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
[7]任秀利 柳艳萍 宋富军 王亭 倪明 张平平 刘明法.1990—2015年天津市滨海新区甲状腺癌 流行特征及长期发病趋势分析[J].国际内分泌代谢杂志,2020,40(02):73.[doi:10.3760/cma.j.issn.1673-4157.2020.02.001]
　Ren Xiuli,Liu Yanping,Song Fujun,et al.Epidemiological characteristics and long-term trends of thyroid cancer in Binhai New Area of Tianjin from 1990 to 2015[J].International Journal of Endocrinology and Metabolism,2020,40(01):73.[doi:10.3760/cma.j.issn.1673-4157.2020.02.001]
[8]井超,王旭东.免疫治疗在甲状腺癌中的研究进展[J].国际内分泌代谢杂志,2021,41(05):459.[doi:10.3760/cma.j.cn121383-20210624-06069]
　Jing Chao,Wang Xudong..Research progress of immunotherapy in thyroid cancer[J].International Journal of Endocrinology and Metabolism,2021,41(01):459.[doi:10.3760/cma.j.cn121383-20210624-06069]
[9]赵静,李菲,晏蔚田,等.桥本甲状腺炎患者血浆外泌体miRNA表达谱研究[J].国际内分泌代谢杂志,2022,42(02):108.[doi:10.3760/cma.j.cn121383-20200911-09024]
　Zhao Jing,Li Fei,Yan Weitian,et al.Differential expression profiles of plasma exosomal miRNA in Hashimoto's thyroiditis patients[J].International Journal of Endocrinology and Metabolism,2022,42(01):108.[doi:10.3760/cma.j.cn121383-20200911-09024]
[10]苏钢,洪娟,许继炜,等.桥本甲状腺炎患者外周血miR-454、miR-146a水平及意义探讨[J].国际内分泌代谢杂志,2022,42(03):174.[doi:10.3760/cma.j.cn121383-20210318-03048]
　Su Gang,Hong Juan,Xu Jiwei,et al.Levels and significance of miR-454 and miR-146a in peripheral blood of patients with Hashimoto's thyroiditis[J].International Journal of Endocrinology and Metabolism,2022,42(01):174.[doi:10.3760/cma.j.cn121383-20210318-03048]
[11]于亚静,杨彩哲,关小宏,等.桥本甲状腺炎和甲状腺癌的关系[J].国际内分泌代谢杂志,2014,(03):200.[doi:10.3760/cma.j.issn.1673-4157.2014.03.016]
　Yu Yajing,Yang Caizhe,Guan Xiaohong,et al.Relationship between Hashimoto's thyroiditis and thyroid carcinoma[J].International Journal of Endocrinology and Metabolism,2014,(01):200.[doi:10.3760/cma.j.issn.1673-4157.2014.03.016]

备注/Memo

备注/Memo:
（收稿日期：2014-07-04）
更新日期/Last Update: 2015-03-20